Morgan Stanley Upgrades Novartis (NVS) to Overweight, Raises Price Target to CHF 110
Novartis(US:NVS) Yahoo Finance·2025-11-20 03:02Novartis AG (NYSE:NVS) is included among the 12 Best European Dividend Stocks to Buy Now. Morgan Stanley Upgrades Novartis (NVS) to Overweight, Raises Price Target to CHF 110 Photo by Dan Dennis on Unsplash On October 31, Morgan Stanley upgraded Novartis AG (NYSE:NVS) to Overweight from Equal Weight, raising its price target to CHF 110 from CHF 108, as reported by The Fly. The firm cited an attractive valuation following the recent market sell-off. The analyst noted that Novartis is improving ...